Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
OBJECTIVE: Detecting Alzheimer's disease (AD) at an early stage is essential for administering effective treatments and preventing neuronal damage. Unfortunately, current diagnostic techniques are often invasive and expensive. Our research focuses on creating a cost-effective and non-invasive method for the early detection of cognitive decline. METHODS: Using a publicly available dataset of restin...
INTRODUCTION: Structural MRI analysis for Alzheimer's disease (AD) is limited by balancing group-level comparability in standard space with anatomical fidelity in native space. We therefore propose a multi-space, hybrid-feature framework, integrating radiomics and network metrics from both spaces to classify AD and predict mild cognitive impairment (MCI) progression. METHODS: An integrated dual-sp...
Alzheimer's disease (AD) is a currently incurable neurodegenerative disease, with early detection representing a high research priority. AD is charact...
BACKGROUND: Tears are an easily accessible biofluid that reflects both emotional states and disease conditions. They are particularly enriched in extr...
BACKGROUND: Existing knee osteoarthritis (KOA) severity classification methods typically rely on a combination of object detection algorithms and clas...
Brainstem white matter (WM) bundles are essential conduits for neural signals that modulate homeostasis and consciousness. Their architecture forms th...
Machine learning methods based on imaging and other clinical data have shown great potential for improving the early and accurate diagnosis of Alzheim...
Early and accurate diagnosis of Alzheimer's Disease (AD) is critical for effective disease management and progression delay. Researches have been done...
BACKGROUND: Brain age gap (BAG)-the difference between predicted and chronological age-captures neurobiological aging, but MRI-only models insufficien...
BACKGROUND: Cancer remains a leading global health burden. Artificial intelligence offers new opportunities to address complex physical and psychologi...
Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, with no known cure. Early detectio...
Ferroptosis, an iron-dependent regulated cell death form, is a key pathogenic mechanism in Alzheimer's disease (AD), especially in the entorhinal cort...
BACKGROUND: Heterogeneity in the long-term progression of Alzheimer's disease (AD) challenges the efficiency of clinical trials. Identifying long-term...
Neurodegenerative diseases represent a major and growing clinical challenge due to their progressive nature, biological heterogeneity, and limited the...
The advent of anti-amyloid therapies (AATs) for Alzheimer disease (AD) has elevated the importance of MRI surveillance for amyloid-related imaging abn...
Voxel-based morphometry (VBM) using T1-weighted magnetic resonance imaging is a pivotal tool for assessing brain structure and identifying subtle morp...
As artificial intelligence (AI) is increasingly integrated into medical diagnostics, it is essential that predictive models provide not only accurate ...
BACKGROUND: The objective of this study was to construct a predictive model using multiple machine learning algorithms to predict the risk of dementia...
Millions of individuals worldwide suffer from Alzheimer's disease (AD), a chronic, incurable neurological disorder. For the longevity of people, a com...
BackgroundThe retrosplenial cortex (RSC) is a cortical area that functions as a key component of the core network of brain regions involved in cogniti...